全血输血与失血性休克合并创伤性脑损伤患者死亡率的相关性
本研究回顾性分析美国外科医师学会创伤质量改进项目2020年1月至2021年12月数据,纳入年龄≥18岁、到院4小时内需输血且头部简明损伤定级>2的失血性休克合并创伤性脑损伤患者15967例,其中2725例(17.0%)接受全血输血。经1:1倾向性评分匹配后比较2720对患者,全血输血与非全血输血相比30天死亡率无显著差异(34.0% vs 34.7%,比值比0.97,95%置信区间0.87-1.09)。结论认为全血输血与降低30天死亡率无关。
要点
- 失血性休克合并创伤性脑损伤患者中,全血输血组与非全血输血组30天死亡率无显著差异。
- 匹配后全血输血组30天死亡率为34.0%,非全血输血组为34.7%,比值比0.97(95%置信区间0.87-1.09)。
- 作者认为并非所有失血性休克患者都能从全血输血中获益。
核心结论
- 全血输血与失血性休克合并创伤性脑损伤患者30天死亡率降低无关。
- 作者认为这些发现提示并非所有失血性休克患者都能从全血输血中获益。
研究设计与样本
- 回顾性分析美国外科医师学会创伤质量改进项目2020年1月至2021年12月的数据。
- 纳入年龄≥18岁、到院4小时内需输血且头部简明损伤定级>2的创伤性脑损伤患者。
- 共15967例患者符合分析条件,其中2725例(17.0%)接受全血输血。
- 对人口学特征、损伤类型、入院生命体征、创伤性脑损伤特征、损伤特征、合并症、出血控制操作、医院特征及生命支持撤除进行1:1倾向性评分匹配后,比较2720对患者的30天生存率。
主要发现
- 匹配后患者中位休克指数为1.0,需立即输血的最低收缩压为79 mm Hg。
- 全血输血组30天死亡率为34.0%,非全血输血组为34.7%,比值比0.97(95%置信区间0.87-1.09)。
- 全血输血与非全血输血相比,30天死亡率无显著差异。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVES: Whole blood (WB) transfusion in trauma has been revisited, and recent studies have reported an association between WB and improved survival among patients with hemorrhagic shock. However, no evidence of a similar association exists for patients with hemorrhagic shock and traumatic brain injury (TBI). This study aimed to assess the association between WB and mortality among patients with hemorrhagic shock and TBI. METHODS: This study retrospectively analyzed data obtained from American College of Surgeons-Trauma Quality Improvement Program during January 2020 to December 2021. Patients (age ≥18 years) requiring blood transfusion within 4 hours of hospital arrival and sustaining TBI (head Abbreviated Injury Scale >2) were included. Survival at 30 days were compared after performing 1:1 propensity score matching for demographics, injury type, vital signs on admission, TBI characteristics, injury characteristics, comorbidities, hemorrhage control procedures, hospital characteristics, and withdrawal of life support. RESULTS: A total of 15 967 patients were eligible for analysis. The median age was 42 years (interquartile range: 28-60 years); 11 789 (73.8%) patients were male, and 10 102 (63.2%) patients were White. Of them, 2725 (17.0%) received WB. After a 1:1 propensity score matching, 2720 matched pairs were compared. Matched patients had 1.0 as median shock index and 79 mm Hg as the lowest systolic blood pressure requiring immediate transfusion. WB was not associated with reduced 30-day mortality, compared with non-WB (34.0% vs 34.7%, odds ratio: 0.97, 95% confidence interval: 0.87-1.09). CONCLUSION: WB was not associated with reduced 30-day mortality among patients with hemorrhagic shock and TBI. These findings suggest that not all patients with hemorrhagic shock would benefit from WB.
引用
- Aoki M, Katsura M, Matsushima K, et al. Association Between Whole Blood Transfusion and Mortality Among Patients With Hemorrhagic Shock and Traumatic Brain Injury. Neurosurgery. 2024. PMID: 39248469. doi:10.1227/neu.0000000000003161
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。